Drug safety and toxicology studies aim to assess the potential risks and benefits of a drug before it is approved for use.

The FDA is responsible for ensuring the safety and efficacy of drugs before they are marketed in the United States.

Toxicology is the study of the effects of drugs and other chemicals on living organisms.

Acute toxicity studies evaluate the effects of a drug over a short period of time, typically up to 14 days.

Pharmacokinetics is the study of the absorption, distribution, metabolism, and excretion of drugs in the body.

Teratology studies evaluate the effects of a drug on the reproductive system, including the potential for birth defects.

Chronic toxicity studies evaluate the effects of a drug over a long period of time, typically more than 90 days.

Carcinogenicity studies evaluate the potential of a drug to cause cancer.

Neurotoxicity studies evaluate the effects of drugs on the nervous system.

Mutagenicity studies evaluate the potential of a drug to cause genetic damage.

Immunotoxicity studies evaluate the effects of drugs on the immune system.

Teratology studies evaluate the potential of a drug to cause birth defects.

Cardiotoxicity studies evaluate the effects of drugs on the cardiovascular system.

Hepatotoxicity studies evaluate the potential of a drug to cause liver damage.

Nephrotoxicity studies evaluate the effects of drugs on the kidneys.